BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33230258)

  • 1. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.
    Du Y; Kong C
    Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
    Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
    J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.
    Song Z; Li Z; Han W; Zhu C; Lou N; Li X; Luo G; Peng S; Li G; Zhao Y; Guo Y
    Aging (Albany NY); 2020 Nov; 13(2):1842-1858. PubMed ID: 33201837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
    Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X
    J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.
    Horiguchi A; Asano T; Kuroda K; Sato A; Asakuma J; Ito K; Hayakawa M; Sumitomo M; Asano T
    Br J Cancer; 2010 May; 102(11):1592-9. PubMed ID: 20461084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.
    Mitsui Y; Chang I; Fukuhara S; Hiraki M; Arichi N; Yasumoto H; Hirata H; Yamamura S; Shahryari V; Deng G; Wong DK; Majid S; Shiina H; Dahiya R; Tanaka Y
    BMC Cancer; 2015 Dec; 15():942. PubMed ID: 26626260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
    Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
    Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
    Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
    Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 Regulates the Proliferation, Differentiation, and Apoptosis of Human Renal Cell Carcinoma Cells by the mTOR-STAT3 Signaling Pathway.
    Liang T; Hu XY; Li YH; Tian BQ; Li ZW; Fu Q
    Oncol Res; 2016; 24(5):371-380. PubMed ID: 27712594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
    Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
    Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
    Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
    Yu H; Liu J; Zhang Z; Zhu Y; Bi J; Kong C
    J Cell Mol Med; 2021 May; 25(10):4696-4708. PubMed ID: 33787057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
    Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.
    Li P; Weng Z; Li P; Hu F; Zhang Y; Guo Z; Shen W; Zhao C; Dai S
    Cancer Gene Ther; 2021 May; 28(5):400-412. PubMed ID: 33057139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
    Liu Y; Song J; Liu Y; Zhou Z; Wang X
    J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.